The feasibility of storing ovarian tumor cells on databasing paper: Establishing a library of ovarian cancer DNA

International Journal of Gynecological Cancer

Volumn 17, Issue 1, 2007, Pages 94-100

  Galaal, K ^a   Meirovitz, M ^a   Hussain, R ^b   Allcroft, L ^b   Sullivan, N ^b   Lopes, A ^a   Edmondson, R J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b Business and Innovation Centre ^*  (United Kingdom)

Author keywords

Ovarian cancer; Paper matrix; Tissue storage

Indexed keywords

COLLAGENASE; COMPLEMENTARY DNA; DNA; RNA; TRYPSIN;

ARTICLE; CELL COUNT; CELL SUSPENSION; CONTROLLED STUDY; DNA LIBRARY; FEASIBILITY STUDY; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

BASE SEQUENCE; DNA, NEOPLASM; FEASIBILITY STUDIES; FEMALE; GENE LIBRARY; HUMANS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; PAPER; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SPECIMEN HANDLING;

EID: 33846807768     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00755.x     Document Type: Article

References (24)

1. Sanseverino F, D'Andrilli G, Petraglia F, Giordano A. Molecular pathology of ovarian cancer. Anal Quant Cytol Histol 2005;27:121-4.
2. Wenham R, Lancaster J, Berchuck A. Molecular aspects of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 2002;16:483-97.
3. Schuyer M, Henzen-Logmans SC, van der Burg ME et al. Genetic alterations in ovarian borderline tumours and ovarian carcinomas. Eur J Obstet Gynecol Reprod Biol 1999;82:147-50.
4. Laframboise S, Chapman W, McLaughlin J, Andrulis I. p53 Mutations in epithelial ovarian cancers: possible role in predicting chemoresistance. The Cancer Journal 2000;6:302-8.
5. Gadducci A, Cosio S, Muraca S, Genazzani A. Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications. Eur J Gynaecol Oncol 2002;23:390-6.
6. Vikhanskaya F, Broggini M. Genetic alterations in ovarian cancer cells that might account for sensitivity to chemotherapy in patients. Int Rev Cytol 2002;219:157-98.
7. Makhija S, Sit A, Edwards R et al. Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer. Gynecol Oncol 2003;90:3-9.
8. Dobbs L, Madigan M, Carter A, Earls L. Use of FTA gene guard filter paper for the storage and transportation of tumor cells for molecular testing. Arch Pathol Lab Med 2002;126:56-63.
9. Smith L, Burgoyne L. Collecting, archiving and processing DNA from wildlife samples using FTA databasing paper. BMC Ecol 2004;4:4.
10. Barbaro A, Cormaci P, Barbaro A. Detection of STRs from body fluid collected on IsoCode paper-based devices. Forensic Sci Int 2004;146(Suppl.):S127-8.
11. Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991;10:506-13.
12. Giraffa G, Rossetti L, Neviani E. An evaluation of chelex-based DNA purification protocols for the typing of lactic acid bacteria. J Microbiol Methods 2000;42:175-84.
13. Butler M, Dawson M. Cell culture labfax. Oxford, UK: Bios Scientific Publishers Limited and Blackwell Scientific Publications Ltd, 1992.
14. Kidd RS, Curry TB, Gallagher S, Edeki T, Blaisdell J, Goldstein JA. Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin. Pharmacogenetics 2001;11:803-8.
15. Bozina N, Granic P, Bozina N, Granic P, Lalic Z, Tramisak I, Lovric M, Stavljenic-Rukavina A. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population. Croat Med J 2003;44:425-8.
16. Tracey M. Short tandem repeat-based identification of individuals and parents. Croat Med J 2001;42:233-8.
17. Ruitberg C, Reeder D, Butler J. STRBase: a short tandem repeat DNA database for the human identity testing community. Nucleic Acids Res 2001;29:320-2.
18. Altschul S, Gish W, Miller W, Myers E, Lipman D. Basic local alignment search tool. J Mol Biol 1990;215:403-10.
19. National Center for Biotechnology Information, National Institutes of Health. Available at: http://www.ncbi.nih.gov/BLAST/
20. Annunziata C, Kohn E. Is there a genomic basis for primary chemoresistance in ovarian cancer? Gynecol Oncol 2003;90:1-2.
21. Cordon-Cardo C. Applications of molecular diagnostics: solid tumor genetics can determine clinical treatment protocols. Mod Pathol 2001;14:254-7.
22. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
23. Ndunguru J, Taylor N, Yadav J et al. Application of FTA technology for sampling, recovery and molecular characterization of viral pathogens and virus-derived transgenes from plant tissues. Virol J 2005;2:45.
24. Rogers C, Burgoyne L. Reverse transcription of an RNA genome from databasing paper (FTA(R)). Biotechnol Appl Biochem 2000;31:219-24.